|
|
|
09108
|
|
|
P.I.:
|
Amrita Krishnan, MD
|
(Cooperative Group)
|
|
Title:
|
BMT CTN 0702: A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
|
| | |
|
|
09096
|
|
|
P.I.:
|
Amrita Krishnan, MD
|
(Institutional)
|
|
Title:
|
A Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of Bendamustine in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma
|
| | |
|
|
09070
|
|
|
P.I.:
|
Amrita Krishnan, MD
|
(NCI Approved External Peer Review)
|
|
Title:
|
Pilot Survey of Outcome in Patients with HIV Related Lymphomas by Analysis of CCR5 Genotype, HIV Infection Status, and Immunity to Selected Tumor Markers
|
|
|
07076
|
|
|
P.I.:
|
Amrita Krishnan, MD
|
(NCI Approved External Peer Review)
|
|
Title:
|
A Phase II Study of Yttrium-90-Labeled Anti-CD20 Monoclonal Antibody in Combination with High-Dose Beam (BCNU, Etoposide, Cytarabine and Melphalan) Followed by Autologous Stem Cell Transplantation for Patients with Poor Risk/Relapsed B-Cell Lymphoma
|
| | |
|
|
99067
|
|
|
P.I.:
|
Amrita Krishnan, MD
|
(NCI Approved External Peer Review)
|
|
Title:
|
High Dose Chemotherapy and Combination anti-HIV Therapy for HIV-Associated Hodgkin's and Non-Hodgkin's Lymphoma
|
| | |
|